r2rtf
The clinical-report table engine learned Chinese, then learned to leave RTF entirely
Comparison · Analytics
Appinio vs DoseFinding
A side-by-side editorial comparison of Appinio and DoseFinding — release velocity, themes, recent moves, and the top alternatives to consider.
Appinio vs DoseFinding: at a glance
What is Appinio?
Appinio is layering AI across the research workflow, from survey draft to reusable insight.
Appinio is steadily wrapping its survey platform in AI: importing drafts from any document format, generating sentiment and multi-question insights on results, and turning past studies into a queryable knowledge base. The non-AI work is polish — dark mode, white-labeled sharing, flexible KPI displays, richer significance testing — aimed at making the tool presentable to stakeholders. The shape is a research tool trying to compress the distance between fielding a survey and acting on it.
What is DoseFinding?
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
Appinio vs DoseFinding: editorial side-by-side
Appinio
0.0ANALYTICS
Appinio is layering AI across the research workflow, from survey draft to reusable insight.
◆ Current state
Appinio is steadily wrapping its survey platform in AI: importing drafts from any document format, generating sentiment and multi-question insights on results, and turning past studies into a queryable knowledge base. The non-AI work is polish — dark mode, white-labeled sharing, flexible KPI displays, richer significance testing — aimed at making the tool presentable to stakeholders. The shape is a research tool trying to compress the distance between fielding a survey and acting on it.
◆ Where it's heading
Direction is toward AI handling the tedious ends of research: setup and synthesis. The questionnaire importer removes data entry at the front; sentiment analysis and the cross-survey knowledge base remove manual reading at the back. If the knowledge base graduates from beta, Appinio shifts from a per-study tool toward an institutional research memory.
◆ Prediction
Expect the beta knowledge base to reach general availability and connect to the AI insights engine, so users query across all historical surveys rather than analyzing one at a time.
DoseFinding
0.0ANALYTICS
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
◆ Current state
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
◆ Where it's heading
The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.
◆ Prediction
Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.
Alternatives to Appinio and DoseFinding
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either Appinio or DoseFinding.
webmockr
The stubbing library added httr2 support, then spent a year cutting itself free of everything else
crul
crul took mocking back from webmockr and made it a property of the client itself
dendroNetwork
Six releases, six identical bodies — the feed carries the package abstract instead of release notes
chattr
chattr deleted every LLM integration it had written and outsourced the lot to ellmer
cloudml
Six years since the last functional change, and Google renamed the service it wraps in the release before that
See all Appinio alternatives → · See all DoseFinding alternatives →
Recent activity from Appinio and DoseFinding
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 9mo agoAppinioAI-Powered Questionnaire Importer
- 9mo agoAppinioHello, Dark Mode ð
- 11mo agoAppinioAdditional KPIs, clearer insights | Top-bottom 3â5 metrics, sorted your way
- 1y agoAppinioWhite-labeled public links | Share insights under your own brand
- 1y agoAppinioSentiment Analysis | Add emotional context to open-ended questions
- 1y agoDoseFindingConditional and predictive power for interim analyses
- 1y agoAppinioAll your research, now your own knowledge base ⚡
- 1y agoDoseFindingModel averaging arrives for dose-response fitting ⚡
- 1y agoDoseFindingPackage moves to openpharma under new maintainership
- 2y agoDoseFindingCompliance update for R-devel
- 3y agoDoseFindingpowMCTBinCount bug fix
Frequently asked questions
What is the difference between Appinio and DoseFinding?
They serve adjacent needs but don't currently overlap on shipped themes. Appinio and DoseFinding are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is Appinio better than DoseFinding?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. Appinio and DoseFinding are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to Appinio?
Top Appinio alternatives in Analytics are ranked by recent ship velocity. Browse the "Appinio alternatives" section above for the current picks, or visit /alternatives/appinio for the full list with editorial commentary on each.
What are the best alternatives to DoseFinding?
Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.